On this page you will find our recommendations sorted by BNF chapter.

Appraisal Reports are available to stakeholders on request.

Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary onĀ nuth.nyrdtc.rxsupp@nhs.net

Title Documents Decision Date


Top Tips and Recommendations for Dapagliflozin [FORXIGA] in Chronic Kidney Disease (CKD) Dapagliflozin in CKD Top Tips NTAG v1 - approved June 2022 Approved by NTAG 07/06/2022


SGLT2-inhibitors and Chronic Kidney Disease - Patient Information Leaflet SGLT2 CKD PIL NTAG v1 Approved by NTAG 07/06/2022